Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02946021Phase 2Completed
Phase 2, open-label trial (2 arms), sponsored by Tactile Medical. Primary endpoint: Lymph Movement Measured by ICG Lymphography at 2 Weeks. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02946021.